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 30 
Abstract 31 
Background: Adolescent girls in sub-Saharan Africa are disproportionally vulnerable to sexual and 32 
reproductive health (SRH) harms. In western Kenya, where unprotected transactional sex is 33 
common, young females face higher rates of school dropout, often due to pregnancy, and sexually 34 
transmitted infections (STIs), including HIV. Staying in school has shown to protect girls against early 35 
marriage, teen pregnancy, and HIV infection. This study evaluates the impact of menstrual cups and 36 
cash transfer interventions on a composite of deleterious outcomes (HIV, HSV-2, and school 37 
dropout) when given to secondary schoolgirls in western Kenya, with the aim to inform evidence-38 
based policy to improve girls’ health, school equity, and life-chances. 39 
Methods: Single site, 4-arm, cluster randomised controlled superiority trial. Secondary schools are 40 
the unit of randomisation, with schoolgirls as the unit of measurement. Schools will be randomised 41 
into one of four intervention arms using a 1:1:1:1 ratio and block randomisation: (1) menstrual cup 42 
arm; (2) cash transfer arm, (3) cups and cash combined intervention arm, or (4) control arm. 43 
National and county agreement, and school level consent will be obtained prior to recruitment of 44 
schools, with parent consent and girls’ assent obtained for participant enrolment. Participants will 45 
be trained on safe use of interventions, with all arms receiving puberty and hygiene education. 46 
Annually, the state of latrines, water availability, water treatment, handwashing units and soap in 47 
schools will be measured. The primary endpoint is composite of incident HIV, HSV-2, and all-cause 48 
school dropout, after three years follow-up. School dropout will be monitored each term via school 49 
registers and confirmed through home visits. HIV and HSV-2 incident infections and risk factors will 50 
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be measured at baseline, mid-line and end-line. Intention to treat analysis will be conducted among 51 
all enrolled participants. Focus group discussions will provide contextual information on uptake of 52 
interventions. Monitoring for safety will occur throughout. 53 
Discussion: If proved safe and effective, the interventions offer a potential contribution toward girls’ 54 
schooling, health, and equity in low- and middle-income countries. 55 
Trial registration: ClinicalTrials.gov NCT03051789, 15th February 2017 56 
Keywords: Sexual and reproductive health; adolescence; equity; HIV; HSV-2; pregnancy; school 57 
dropout, clinical trial, menstruation, Kenya, study protocol. 58 
 59 
Background 60 
Young persons aged 10-24 years (yr) make up a quarter of the worlds’ population, contributing 1.8 61 
billion persons of whom approximately 90% live in low or middle-income countries (LMIC). 62 
Adolescence is a critical time of psychological and biological change, and advocacy has increased to 63 
identify interventions that protect young peoples’ lives (1). These interventions include ways to 64 
protect against sexual and reproductive health (SRH) harms, which are disproportionately high among 65 
adolescent girls in sub-Saharan Africa (SSA) (2, 3). Each year an estimated 14 million girls aged 15-19yr 66 
give birth (2).  Maternal causes kill more girls in this age group than any other cause (2). Thus, delaying 67 
pregnancy to adulthood is important for women’s reproductive health and infants survival as well as 68 
their economic and social empowerment (4). In much of east and southern Africa including western 69 
Kenya, where unprotected transactional sex is common, young females are highly vulnerable to 70 
sexually transmitted infections (STIs), including HIV which may result in mother-to-child transmission 71 
(2, 3). The burden of young female SRH harms is high for individuals, and on their communities and 72 
health services, yet sustainable preventive interventions are lacking. Evidence of a positive association 73 
between girls’ education, and their health and economic potential, has strengthened international 74 
resolve to improve educational opportunities for adolescent girls. While SRH education has not been 75 
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demonstrated to have a large impact on SRH harms (5), staying in school has shown to protect girls 76 
against early marriage, teen pregnancy, and HIV infection, with schoolgirls reporting less frequent sex, 77 
and fewer partners with less age disparity (6-8). Building on the Millennium Development Goals 78 
(MDG), which focused on primary school attendance, the post-2015 Sustainable Development Goals 79 
encourage investment in secondary, tertiary and vocational education to build human capital, 80 
encourage innovation and spur economic growth (9).  81 
 82 
Intervention studies using cash transfer (CT) have demonstrated a protective effect on girls SRH 83 
(including HIV, HSV-2) and school indicators (8, 10, 11), although results in other studies have been 84 
inconclusive (12, 13). Dropout before secondary school completion is partly explained by girls’ 85 
vulnerability once they engage in premarital sex, which is often a precursor to unintended pregnancy 86 
or early marriage (7, 14, 15). Studies have illustrated adolescent girls’ vulnerability to transactional 87 
or coercive sex, to obtain necessities such as soap, sanitary products, and underwear (16-19). 88 
Products for menstrual hygiene management (MHM) are one such necessity, and their accessibility 89 
remains a pervasive problem in LMIC. A lack of MHM materials, awareness, and facilities, as well as 90 
stigma, negatively impact girls’ school-life (20, 21), and can be a driver of girls’ vulnerability to 91 
coercive sex. In western Kenya, 10% of 15yr old girls self-reported they obtained money through sex 92 
to purchase sanitary products (22). To better understand girls MHM needs in western Kenya, a pilot 93 
study in rural primary schools was conducted measuring girls’ menstrual practices, uptake, and 94 
safety of a reusable menstrual cup (MS Pilot Study) (23, 24). The pilot results demonstrated 95 
acceptability of the menstrual cup (25), with a lower prevalence of STI and bacterial vaginosis found 96 
at 9 and 12 month follow-up among girls using the cup when compared to controls (26), and good 97 
clinical safety (16). Prevalence of school dropout after 12 months was lower but inconclusive due to 98 
the small sample (26).  99 
 100 
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To verify the results of the MS Pilot Study and examine the efficacy, safety, and cost-effectiveness of 101 
different school-based interventions in improving girls’ SRH, schooling, and life-chances in rural 102 
western Kenya, a randomized controlled trial was designed with a larger population and follow-up 103 
duration. The study is designed to inform evidence-based policy to improve girls’ health, school 104 
equity and their life-chances which is summarised in this article.  105 
 106 
Methods 107 
Design Overview 108 
This study is a single site, open-label, 4-arm, school-cluster randomised controlled superiority trial 109 
taking place in Siaya County, western Kenya. Schools are the unit of randomisation (clusters), with 110 
girls as the unit of measurement. Schools will be randomly allocated into 4 arms using a 1:1:1:1 ratio 111 
and block randomisation to minimise bias. Enrolment will open in the first school term of 2017 after 112 
trial registration and continue until we reach the necessary sample. Girls will be followed-up through 113 
graduation and into employment or up to 10 academic terms to determine if they complete 114 
secondary school (Form 4), see Appendix 1: Spirit Checklist.  115 
 116 
Primary objective 117 
To determine the impact of menstrual cups or CT alone, or in combination, on a composite of 118 
deleterious outcomes (HIV, HSV-2, and school dropout) when given to secondary schoolgirls in 119 
western Kenya. 120 
 121 
Secondary objectives 122 
1. To measure the age-specific differences in the acquisition of HIV and HSV-2 infections in 123 
secondary schoolgirls and risk factors for incident HIV and HSV-2 infections.  124 
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2. To determine the risk, risk factors and reasons for dropout and other school indicators among 125 
secondary schoolgirls examining the influence of social, epidemiological, and/or health 126 
characteristics.  127 
3. To determine the cost benefit of menstrual cup and CT programmes for schoolgirls by assessing 128 
the cost savings of outcomes averted, for individual and combined interventions, and resulting 129 
societal impact.  130 
4. To determine the safety of menstrual cup use, including risk of cup contamination over time, 131 
serious adverse events, and identify factors that increase or modify this risk.  132 
5. To determine factors affecting how adolescent girls spend CT money, and what training is 133 
required to support their financial literacy and decision-making.  134 
6. To determine any adverse outcomes associated with CT and evaluate ways to mitigate risk.  135 
7. To determine the impact of the interventions on girls' sexual behaviours, including age of sexual 136 
début, coerced sex, number of partners, age of partners, pregnancy, condom use and use of 137 
contraception.  138 
8. To examine programme implementation for interventions in schools, working with beneficiaries 139 
and stakeholders to develop programme implementation packages.  140 
 141 
Design Considerations 142 
Why secondary schoolgirls? 143 
Among schools located in our proposed study area, the dropout rates are higher among girls in 144 
secondary when compared to primary school girls.  Unpublished school enrolment data for 2015 in 145 
the study location shows that only 26% of primary school girls drop out of primary school compared 146 
to 36% who drop out of secondary school (local school enrolment data, unpublished). These high 147 
dropout rates for secondary schoolgirls exert a high burden on the national economy, with lifetime 148 
cost of dropout estimated to be 48% of GDP (4). Our pilot study found that following the abolition of 149 
primary school fees 6 years ago, girls complete primary at a younger age (<15yr). Thus, fewer girls in 150 
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primary school reach menarche and sexual debut. While prevalence of HIV was low in our primary 151 
school cohort (<1%), health studies in the same study area have documented very high HIV 152 
incidence for secondary school-aged girls, who range in age from 13-30. In one study, HIV prevalence 153 
was 8.8% in 15-19yr olds, sharply rising from 1.3% among 13-14yr olds to 3.3% in 16yr olds and 154 
12.8% in 18yr olds (27). A similar steep increase by age was seen in HSV-2 prevalence (27). A high 155 
prevalence of STIs was detected in 15-19yr old girls in neighbouring Kisumu (28). In pilot study focus 156 
group discussions (FGDs), when asked about reasons for drop out, girls voiced reasons linked to 157 
exposure to sexual activity (resulting from alcohol, funeral parties, needs for money, and coercive 158 
sex), and these were more frequently stated among older girls (17). During these FGDs, girls were 159 
able to vocalise their concerns about pregnancy risks, and issues around lack of money for school 160 
and personal needs. They reported that their menstrual needs were unmet but a high priority and at 161 
times compelled them to have sex to obtain money to buy pads (17). In a separate study in the same 162 
area, 10% of 15yr olds surveyed reported they had sex for money in order to purchase sanitary pads 163 
(22). 164 
 165 
Justification for a composite endpoint 166 
The primary composite endpoint will include incident HIV, HSV-2, and school dropout in girls sero-167 
negative or for both HIV and HSV-2 on enrolment or undetermined sero-status at enrolment 168 
(conservatively the sample size allows for 20% refusal for testing at baseline). The presence of HIV or 169 
HSV-2 at enrolment precludes the components from contributing to the primary composite 170 
endpoint. Thus, among HIV-negative girls who were HSV-2 positive on enrolment only incident HIV 171 
infection and school dropout would contribute to the primary endpoint; among girls who are both 172 
HIV and HSV-2 positive on enrolment, only school dropout would contribute. This endpoint 173 
represents the key drivers compromising girls’ health and life chances into adulthood. The rationale 174 
behind this composite endpoint is to increase the power for a given sample and to build a single 175 
outcome across all girls regardless of their independent HIV and/or HSV-2 status at enrolment. 176 
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 177 
Justification for cumulative school dropout 178 
The cumulative risk of school dropout among secondary schoolgirls is an acute problem in western 179 
Kenya; 36% of girls drop out before the start of the fourth and final year of secondary school due to 180 
teen-age pregnancy, lack of school funds, illness, work or family commitments, or viewing school as 181 
unnecessary (17). The need for MHM is also perceived as a constant stressor impacting school-life 182 
given that traditional MHM items (rags, paper, etc) leak, cause odour and discomfort, and cause girls 183 
to habitually miss school and fall behind. Some evidence suggests that poor MHM even leads some 184 
to engage in transactional sex for essential ‘luxuries’ such as pads and soap (17, 22). During the pilot 185 
study (23-25), we found that use of MHM products (reusable menstrual cups or pads) for at least 1 186 
year had the potential to prevent school dropout (26). CT programs also have shown potential for CT 187 
improving the odds of being enrolled in and attending school, improving household socio-economic 188 
status (SES) and quality of life, and reducing early marriage (29, 30). In the trial, we define dropout 189 
as not attending school consecutively for at least 1 term or longer. Girls who attended part or all of 190 
Form (class) 4, but then do not sit the final national Kenya Secondary Certificate of Education (KSCE) 191 
exams will be considered a dropout in that final term. Other secondary school indicators such as 192 
grade repetition will also be documented. Girls who return to school after being classified as a 193 
dropout will be classified as re-enrolled.  194 
 195 
Justification for cumulative risk of incident HIV and HSV-2 196 
Risky sexual exposure can cause harm to a girl’s sexual and reproductive health and negatively affect 197 
her life-chances even while remaining in school. The pilot showed high prevalence of laboratory 198 
confirmed STIs in this rural area in western Kenya even among primary schoolgirls (28% of girls had 199 
reproductive tract infections, predominantly bacterial vaginosis) (26, 31). Community surveys in the 200 
pilot site found an HIV prevalence of 11% among females under 30yr, rising from 1% in 15yr to 20% 201 
by age 29 (22, 27), and a reported 52% of girls in this area engaging in transactional sex for money, 202 
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gifts or services (32). HSV-2 is the most common cause of genital ulcer disease worldwide, the most 203 
prevalent STI in sub-Saharan Africa, and a well-established biomarker for sexual risk behaviour (8, 204 
33, 34). Evidence suggests HSV-2 prevalence in girls in the study area increases from 10% in 13-14yr 205 
to 28% in 15-19yr, and 70% among the 20-24yr (27, 35). 206 
 207 
A trial in Malawi that provided CT to school girls aged 13-22yr found that HIV and HSV-2 prevalence 208 
were 33% and 70% lower respectively in CT recipients after 18m intervention when compared to 209 
controls (8). Results were supported with reduced frequencies of self-reported sexual activity and 210 
less age discordant sex (8). The impact of menstrual cups on HIV or HSV-2 has not been evaluated, 211 
but when assessed during the pilot study, cups were associated with a lower prevalence of STIs and 212 
bacterial vaginosis (26), both important risk factors for HIV acquisition and transmission (36-38). This 213 
information corroborates reported narratives that control-arm girls most acutely felt the need to 214 
have sex to obtain sanitary pads (24, 25). Laboratory confirmation of infections is essential, however, 215 
as girls and young women’s reported symptoms are poorly predictive of infection (31, 39-43). 216 
 217 
Study setting 218 
The study will be conducted in in schools in Siaya County in rural western Kenya, extending to 219 
contiguous areas that include Kisumu County if needed. The site is in a health and demographic 220 
surveillance system (HDSS) positioned 400 km west of Nairobi, with its southernmost point reaching 221 
Lake Victoria (44). The population are mostly members of the Luo ethnic group, and are mainly 222 
subsistence farmers (45). Siaya is an impoverished area, with previous studies estimating households 223 
have a mean annual income approximating $600 to $700 (46). An estimated four out of ten child 224 
learners miss school daily in Siaya County (47). Gender equity seen in primary school falls during 225 
adolescence, with between 25%-33% more boys than girls attending secondary school by age 18 (48, 226 
49). The disease burden typifies rural African communities (44), with mortality in adolescents and 227 
young adults attributed to communicable diseases, injuries (50), and maternal causes (51). Advances 228 
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in antiretroviral therapy (ART) access have been associated with reducing adolescent and young 229 
female mortality by half (50, 52). Physical and sexual violence against females is one of the highest in 230 
Kenya, with 12% of women reporting their first sexual intercourse was coerced (53), rising up to 45% 231 
among adolescent girls (54). The former pilot study evaluating menstrual interventions was 232 
conducted in one of the three sub-divisions within the study area, with water, sanitation, and 233 
hygiene (WASH) observations illustrating presence of latrines and water, but not soap in schools 234 
(23). The menstrual care among the population was examined and illustrate girls’ and young 235 
women’s preference for commercial pads over traditional items; with 10% of 15yr olds reporting 236 
they had sex for money to purchase sanitary pads (22). Schools and health facilities have been geo-237 
located (see Figure 1, below). 238 
 239 
Figure 1 – Map of Siaya County Public Health Facilities and 96 CCG Study Schools 240 
 241 
Eligibility criteria: schools 242 
Inclusion criteria for schools 243 
 Secondary school within study area 244 
 Girls or co-educational school 245 
 Day school  246 
 Approval by Head Teacher  247 
 248 
Exclusion criteria for schools 249 
 Boys only school  250 
 Boarding schools 251 
 Special needs schools (i.e. for the blind) 252 
 253 
Eligibility criteria: participants 254 
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Inclusion criteria for participants 255 
 Attend secondary day schools in the study area  256 
 Resident of the study area 257 
 Have a history of established menses (>=3 times) 258 
 Have no disability preventing participation 259 
 Assent to participating in the study and have received parent or guardian consent  260 
Exclusion criteria for participants 261 
 Attend boarding schools 262 
 Visibly pregnant or declare pregnancy at baseline (girls who don’t declare pregnancy but whose 263 
delivery dates confirm pregnancy started prior to enrolment will be excluded from the analysis.)  264 
 265 
Trial interventions 266 
Schools will be randomised to one of 4 arms:  267 
1. One menstrual cup with training on safe use and care, with handwash soap termly. 268 
2. Cash transfer (CT) Ksh 1500/term plus financial literacy training. 269 
3. Combined menstrual cup and CT with training on financial literacy and cup safe use and care. 270 
4. ‘Usual practice’ control (control arm), with handwash soap termly. 271 
All participants regardless of school cluster will receive puberty and hygiene education. 272 
 273 
Menstrual cup 274 
The menstrual cup is a medical grade silicone bell shaped container which is inserted into the vagina 275 
to collect menstrual flow, and requires emptying at regular intervals (4-8 hours) (55). Cleaning by 276 
boiling is recommended at the end of each cycle. The Mooncup® will be used in the t/rial (56), selected 277 
because it has been tested in the UK (57, 58) and internationally (26, 59), is produced to ISO 278 
13485:2003 standards, and registered by the U.S. Food and Drug Agency of Medicines (FDA; 279 
Registration Number 3009117944); and was successfully used in the pilot study (54). Further, its’ white 280 
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colour when new, changing to brown after use, allows physical observation of use (26). Girls will 281 
receive school-based training on safe cup use and care (including insertion, emptying, re-insertion, 282 
cleansing, and storage). The trial will document girls’ use over time. 283 
 284 
Cash transfer pocket money 285 
Cash transfer (CT) programmes are a popular social protection tool in developing countries that aim, 286 
among other things, to improve education outcomes and reduce risky sexual behaviour (8, 10, 11, 60, 287 
61). A sum of US$5 per month (~Ksh500; exchange December 2015) was recommended for future 288 
studies. CT programmes which were conditional on attendance have been shown to improve school 289 
outcomes more than unconditional or non-monitored (29). This trial will provide Ksh1500 (US$15) per 290 
term (3 terms per school year) for up to 10 academic terms. Conditionality for CT receipt will be based 291 
on 80% or more school attendance in the previous term, in line with other studies (8, 61-64). After 292 
assent, participants in the CT arms will receive school-based financial literacy training and a bank card. 293 
For this trial, Equity Bank pre-paid cash cards will be used for minors after obtaining guardian consent. 294 
Girls must provide a birth certificate and a guardian ID to receive a bank card. Precautions will be taken 295 
to ensure girls have direct access to their accounts but maintain low visibility to minimize the risk of 296 
theft, harassment, or violence. School registries will be assessed retrospectively per term to verify 297 
school attendance, with spot-checks conducted to minimise risk of falsification of registries. The trial 298 
will document girls’ use and spending choices over time.  299 
 300 
Endpoints / Outcome measures 301 
Primary outcome: 302 
Composite: incident HIV, HSV-2, all-cause school dropout by the end of the study. 303 
 304 
Secondary outcomes: 305 
 School dropout  306 
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 HSV-2 incidence  307 
 HIV incidence 308 
 Reported sexual behaviour indicators (including age at sexual debut, age-discordance of partners, 309 
coercive sex, number of sexual partners, pregnancy, condom use, and use of modern 310 
contraceptives)  311 
 School performance indicators (Kenya Certificate of Secondary Education [KCSE] results, grade 312 
repetition, prevalence of re-enrolment, and absenteeism) 313 
 Quality of life using EuroQoL and PEDSQL  314 
 Cost-effectiveness of interventions from the societal, including girls’, perspective 315 
 316 
Safety endpoints 317 
 Tolerability: any adverse events assessed in a general reproductive health questionnaire 318 
 Primary Safety:  319 
o Toxic Shock Syndrome 320 
o Violence associated with interventions provided      321 
 Secondary Safety:  322 
o E. coli growth on sampled cups 323 
o Other emergent harms that may occur with provision of cash pocket money or cups. 324 
 325 
Sample Size estimates 326 
Original trial design sample size estimate: Sample size and power calculations were performed for the 327 
minimum number of schoolgirls needed in the proposed 4-arm trial using sample size calculation 328 
software (NCSS/PASS); calculations were validated using SAS based simulation studies. Five primary 329 
comparisons of the primary endpoint were tested: (1) menstrual cup vs usual practice, (2) CT vs usual 330 
practice, (3) combined CT and cup vs usual practice, (4) combined CT and cup vs menstrual cup only, 331 
and (5) combined CT and cup vs CT only. Calculations were based on a 2-sided alpha of 0.01 to allow 332 
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5 primary comparisons of interest, assuming an ICC value of 0.008. Taking a target of mid-late Form-1 333 
of schools in the study area gives a sample size average of 46 girls, a 1yr enrolment period, a 5% overall 334 
refusal to take part in the study, 20% refusal at enrolment to consent to HIV testing among 335 
participating girls, an average of 10 terms (~3.3yr) follow-up through the end of Form-4, and 20% loss 336 
to follow-up or refusal to provide biological samples at the end of the study period. Of 46 enrolled 337 
girls/school, on average, 35 (0.95*0.80x46) will contribute to the primary analysis; we assume that 6.9 338 
will be HSV-2 or HIV positive on enrolment (24.7% of 28 girls who agree to testing) and the remaining 339 
28.1 will be HSV-2/HIV negative (n=21.1) or of unknown HSV-2/HIV sero-status (n=7) because no 340 
assent/consent was provided for testing at enrolment. With these assumptions,  a trial with 4 arms of 341 
21 schools per arm (84 schools total) enrolling 46 girls/school (i.e. 966/arm; 3864 girls total) with 35 342 
girls/school contributing to analysis, will have 90% power to detect a 25% reduction (Relative Risk 343 
[RR]=0.75) in the 3.3yr incidence risk of the primary endpoint from 44.1% in the control group to 33.1% 344 
with either intervention, and 80% power to detect a 22.2% reduction (RR=0.778) to 34.3% (both at 345 
alpha=0.01).  346 
 347 
Source data: The ICC value of 0.008 was the observed ICC value for the composite endpoint of school 348 
dropout and STIs in our previous pilot study, and 0.0084 for school dropout alone (26). The anticipated 349 
effect sizes of 25% (RR=0.75) for the primary endpoint is based on a model combining the impact and 350 
event frequency of the 3 components of the primary endpoint in the three strata: HSV2/HIV negative 351 
girls (60.2% of the overall sample), HSV-2 or HIV positive girls (19.8% of the sample), and girls for 352 
whom the sero-status is unknown (20% of the sample). The model predicts that a 25% (RR=0.75) 353 
overall reduction from 44.1% to 33.1% with single interventions, or from 33.1% to 24.8% with the dual 354 
intervention can be achieved with the following combination of relative risk reductions for school 355 
dropout and HIV and HSV-2 incidence respectively: 30% and 25.7%; 25% and 34.2%; or 20% and 43.0%. 356 
The anticipated minimum reduction of 30% in dropout is based on an average 31% reduction in a 357 
meta-analysis comparing controls against cash transfer (29), and is more conservative than a 58% 358 
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reduction observed with menstrual cups in year-2 of the pilot (26). The 48.8% reduction in HIV and 359 
HSV-2 incidence is based on a 51.9% reduction observed in year-2 of the pilot study, adjusted for the 360 
fact that baseline HSV2-HIV status would not be available for 12 of 60 girls/school (20%) on enrolment, 361 
3 to 4 of whom may have undetected HSV-2 or HIV on enrolment. The observed relative risk reduction 362 
in the HIV and HSV-2 incidence was 48.8% (based on a 43.4% reduction in STI prevalence by the end 363 
of the previous pilot in 2014) (26). 364 
 365 
(2) Blinded sample size re-estimation 366 
 A blinded sample size re-estimation was conducted in 2017 using the baseline data from all arms 367 
pooled to validate the assumptions made during the original sample size estimations in the trial design 368 
phase. The average number of girls per school and the baseline prevalence of HSV-2/HIV (a proxy for 369 
the anticipated incidence) were lower than anticipated. A sample size re-estimation with pooled data 370 
demonstrated that a total of 96 school clusters (24/arm) are required with an anticipated average of 371 
41.25 girls per cluster to obtain 90% power to detect a 25% (RR=0.75) reduction in the primary 372 
endpoint from 39.3% in the control arm to 29.5% in any of the 3 intervention arms (alpha=0.0167 373 
allowing for 3 primary comparisons against the control arm), with an ICC of 0.008 and allowing for 374 
20% loss to follow-up. This yields a full sample of 3,960 overall, 3,168 of whom are expected to 375 
contribute to the primary endpoint, 33 per cluster. This same sample size provide 80% power to detect 376 
a 25.7% (RR=0.743) reduction from 29.5% in any of the single intervention arms to 21.9% in the 377 
combined intervention arm (alpha=0.025). The total sample size may exceed 3,960 if the average 378 
cluster enrolled has more eligible girls than anticipated as the intention is to give every eligible girl in 379 
each secondary school the opportunity to participate.  380 
 381 
Assignment of interventions 382 
Allocation 383 
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School clusters are the unit of randomisation and girls the unit of measurement. A census of secondary 384 
schools in the area will be used to select the eligible schools. The trial statistician will produce block 385 
randomized groupings of four schools (blocks) using a 1:1:1:1 ratio and based on location and size, 386 
including larger schools (e.g. with more than 20 target girls) for logistical reasons. Arm allocation of 387 
schools to intervention arms will be achieved using community ceremonies. During a public ceremony, 388 
head teachers representing their respective school will be called up with the rest of their blocks for 389 
balanced randomization. The head teachers will each simultaneously pick 1 of 4 coded items, and once 390 
all blocks have completed this process and all schools have been randomly allocated, study arm will 391 
be displayed by opening sealed envelopes and breaking the code. This methodology was informed by 392 
the pilot study where randomisation ceremonies with head teachers were successful (26). 393 
 394 
Blinding 395 
Participants cannot be masked to their treatment arm due to the nature of interventions provided. 396 
Laboratory personnel testing for HIV and HSV-2, investigators, and trial statisticians will be blinded 397 
to the study arm. Field staff will be masked as much as feasible, including those who conduct home 398 
visits to confirm dropout. Bias will also be minimised by use of block randomisation stratified by 399 
school size. An independent person will prepare the sealed envelopes with the study arm allocation. 400 
Study arm allocation will not be recorded in the central database to ensure the trial statistician and 401 
data managers remain blinded throughout the study. This information will be recorded separately 402 
and only be merged with the main database following approval of the statistical analysis plan (SAP), 403 
closure of the databases and submission of a copy to the independent statistician of the Data 404 
Monitoring and Ethics Committee (DMEC). 405 
 406 
Participants’ timeline 407 
Overview  408 
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The participant’s timeline will commence after pre-recruitment preparations, including ministry, 409 
school, and community stakeholder meetings and approvals. Parent consent for their daughters’ 410 
participation will follow the school cluster randomisation ceremonies. Participants’ meetings for 411 
assent, pre-screen enrolment and baseline screening, mid-line screening (second study year), and 412 
end-line screening (third study year) will be held as ‘Health Days’ in randomised schools.   413 
 414 
Figure 2-Flowchart of Randomization and Study Design 415 
 416 
Pre-screen Enrolment, Assent and Baseline Screening 417 
The school enrolment register will be used as the sampling frame to define all target girls in the 418 
study schools. Parents of all girls will be approached at the end of the school information meeting to 419 
request informed consent for (1) the main study, (2) HIV testing and counselling, and (3) blood 420 
storage. Signing will be private and one-to-one with a trained member of the study team. The 421 
enrolment list will be updated at the meeting to record girls transferring out or into the school and 422 
missed parents will be followed up at home for consent.  Reasons for non-consent will be 423 
documented. 424 
 425 
Girls whose parents have consented to their participation in the study will be informed of the study 426 
purpose and procedures. Each girl will individually be asked to give her assent to participate and asked 427 
key eligibility criteria questions (see eligibility criteria: participants, above). Girls who meet the 428 
eligibility criteria will then be invited to participate in the study.  429 
 430 
Participants will privately self-administer a combined demographic, social, behavioural and quality of 431 
life/wellbeing questionnaire using tablets during the ‘Health Day’; absent girls will be invited to 432 
participate at a subsequent ‘Health Day’ when logistically feasible. All relevant information will be 433 
captured in the survey questionnaire. Baseline questions around demographics, use of menstrual 434 
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items, and access to cash and personal bank account will be asked, as well as other secondary 435 
outcomes. Wellbeing will be assessed using the adolescent (12-18yr) 23-item PedsQLTM 4.0 (Paediatric 436 
Quality of Life Inventory; http://www.pedsql.org/), and will measure physical, emotional, social, and 437 
school functioning of children, core dimensions as delineated by WHO (65). 438 
 439 
A baseline clinical survey will be conducted to define pre-intervention HIV and HSV-2 prevalence, and 440 
height, weight, and waist measures of participants. Documentation of population HIV prevalence is 441 
important to understand frequency of mother-to-child transmission of HIV, noted in a Zimbabwean 442 
schoolgirl CT study which only evaluated HIV and HSV-2 at endline (30). However, refusal to have an 443 
HIV or HSV-2 test at baseline will not preclude participants from joining the study. School ‘Health Days’ 444 
will be operated with a trained mobile team at a location at or close to their school. All sample 445 
collection and HIV counselling will be conducted by a team of trained HIV Testing and Counselling 446 
(HTC) staff. Results will not be given then, but separately to participants on an individual level at the 447 
health clinics with trained counsellors and testing and counselling and care facilities. Participants can 448 
visit clinics individually without peer pressure and are encouraged but not obligated to ask their 449 
parents to accompany them.  If consent/assent has been obtained for blood collection, girls will 450 
provide 600uL of blood for HIV and 1.5ml for HSV-2 with any blood not used for these two tests stored 451 
as dried blood spots for future testing of other STIs or vaccine preventable infections, if funding allows. 452 
Blood will be collected through fingerpick and stored and transported in Microtainer EDTA tubes to 453 
KEMRI laboratories for analysis. Blood will be stored for a maximum of 5yr, after completion of the 454 
trial, after which it will be destroyed. 455 
 456 
Midline screening 457 
All participants will be invited to participate in a mid-study behavioural survey to update socio-458 
behavioural characteristics, including marriage status, sexual exposures, and document patterns of 459 
intervention use, problems encountered, and any possible safety issues. Midline HIV/HSV-2 testing 460 
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will be conducted mid-study. These tests and follow-up counselling and treatment will follow the 461 
same methodologies used at baseline. These measurements will allow closer examination of 462 
incidence over time and offer the opportunity to test and counsel participants who exit the study 463 
before the endline survey. Baseline consents and assents include this assessment. Participants are 464 
reminded they have the freedom to withdraw or refuse testing. 465 
 466 
End study screening 467 
Similar to the baseline Health Day, participants will attend an end of study Health Day to complete 468 
an endline behavioural survey to document changes in socio-behavioural characteristics (including 469 
risky sexual behaviours, quality of life/wellbeing measures) and intervention use, problems 470 
encountered, and any perceived harms. Outreach activities to survey enrolled girls who have left 471 
school or dropped out will be conducted if funding is available. HIV and HSV-2 serostatus will be 472 
assessed at this same Health Day to determine incidence among those testing negative at enrolment 473 
and during interim follow-up testing. Careful consideration and coordination with head teachers will 474 
be needed to secure the dates for the final survey to ensure no disruption for girls in Form 4 while 475 
they take final exams. Endline HIV/HSV-2 testing will be conducted on Health Days in safe spaces 476 
among all enrolled girls to protect the confidentiality of baseline HIV positive participants. 477 
Participants are reminded they have the freedom to withdraw or refuse testing.   478 
 479 
Unscheduled visits 480 
School dropout will be assessed every term until the study end. Regular monitoring of school 481 
registers will be conducted to determine dropout among participating girls. Girls who dropout will 482 
be followed-up with an unscheduled visit to the home to understand reasons for dropout and 483 
confirmation of the same, and to identify those that have migrated to a different area who may still 484 
attend school (e.g. are classified as loss to follow-up). An unannounced annual WASH survey will be 485 
conducted at all participating schools, to observe the presence and state of latrines, water 486 
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availability, water treatment, handwashing units and soap.  At any time, participants displaying 487 
adverse events will be assessed by a study nurse, with a triage form evaluating seriousness and 488 
potential relationship with the interventions and tailored AE and SAE forms to document relevant 489 
details (see Appendix 2: SAE Report Form). 490 
 491 
Focus group discussions 492 
FGDs will be held pre-intervention, annually (interim) during the trial, and at the end of the study. 493 
Feedback from these will document participant and other beneficiaries understanding of the 494 
interventions, use, impact and any problems arising. 495 
 496 
Laboratory Procedures 497 
Clinical testing 498 
HIV testing will be conducted in accordance to Kenyan national guidelines(66). HSV-2 will be examined 499 
using Kalon gG2 ELISA test kits (Kalon Biologicals Ltd, Guilford, UK), with quality assurance performed. 500 
Any additional blood collected at baseline, interim, or end of study will be stored for future testing of 501 
other STIs or vaccine preventable infections, if funding allows.  502 
 503 
Cup contamination 504 
A register of all participants receiving cups will be used to randomly select a swatch of used cups by 505 
duration of provision. This will exclude girls who received a replacement cup due to loss, theft, or 506 
damage. Randomly selected participants will be traced and asked if they are willing to swap their 507 
existing cup for a new one, to allow laboratory examination of their cup. Each used cup will be 508 
placed in a separate lock- bag labelled with participant ID and transported to the laboratory and 509 
tested for E coli growth. Cups will be swabbed using polyester tipped swabs moistened in normal 510 
saline and inoculated into both MacConkey (MAC) agar and blood agar (BA) and incubated for 18-24 511 
h at 37°C. After incubation, colony types will be visualized for characteristic morphology of E.coli and 512 
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others from the MAC plates, and subjected first to analytical profile index (API) testing for suspected 513 
E coli growth(67), then incubated for 18-24 h at 37°C. The results will be interpreted using API 514 
software(68).  515 
 516 
Statistical methods 517 
A study statistical analysis plan will be developed during the course of the study for the final analysis. 518 
This will be completed prior to the unblinding of data at database lock.  519 
 520 
Screening failures 521 
A participant who gives informed assent (after parental consent) and is provided with a study ID, but 522 
then is found not to fulfil the eligibility criteria, will be classified as a screening failure and excluded 523 
from the intention-to-treat (ITT) and the per protocol (PP) analysis. Pregnant girls who do not 524 
declare pregnancy at enrolment will be excluded from analysis after the dates of normal (or 525 
otherwise) deliveries confirm that the current pregnancy was ongoing at enrolment. 526 
 527 
Intention-to-treat (ITT) population 528 
The intention-to-treat population (the full analysis population) is defined as all participants who 529 
provided parental consent, themselves assented, and were enrolled into the study.  These girls will be 530 
included in the intention-to-treat analysis regardless of whether they have completed all endline 531 
evaluations. 532 
  533 
Per protocol (PP) population 534 
The per-protocol population within the menstrual cup groups is defined as all participants receiving 535 
the cup with evidence it changed colour showing actual use. For cash transfer, ‘per protocol’ 536 
constitutes all girls receiving the cash intervention until dropout or reaching the endpoint. 537 
Participants documented to have crossed over between school clusters will be excluded. 538 
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 539 
Cost-effectiveness analyses 540 
An economic evaluation will be conducted to provide evidence for the cost-effectiveness of the 541 
three interventions. This will be used to estimate the societal cost consequences and efficiencies of 542 
the intervention packages to inform health service delivery and future policy decisions.  543 
 544 
Safety outcomes 545 
Adverse events (AEs) and serious adverse events (SAEs) will be monitored, managed and recorded 546 
during the study (see Appendix 2: SAE Report Form). AEs will be reported and tabulated for each 547 
treatment arm, overall, and according to body system on a per protocol basis. Intervention 548 
emergent AEs are defined as adverse events that had an onset on the day of the intervention, or 549 
thereafter. AEs that have missing onset dates will be considered to be treatment emergent. No 550 
formal statistical testing will be undertaken. All laboratory data will be listed and summarised. 551 
 552 
Ethics approval and consent to participate 553 
This protocol, the informed parent consent and participant assent documents, and participant 554 
information sheets have been reviewed and approved by the Research Ethics Committees at the 555 
Kenya Medical Research Institute, Nairobi, Kenya (KEMRI protocol #3215) and the Liverpool School 556 
of Tropical Medicine, Liverpool (LSTM protocol #15-005). The Centers for Disease Control and 557 
Prevention gave approval for reliance on the KEMRI IRB (2016-136). Registry approval for trailing 558 
menstrual cups was given by the Kenyan Poisons and Pharmacy Board (ECT_16_07_06). Annual 559 
renewal of approvals by KEMRI, LSTM, and KPPB are required based on reporting of trial activities in 560 
the prior year. 561 
 562 
Discussion 563 
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In this study we are hypothesizing that, as a result of receiving the trial interventions, participating 564 
adolescent girls’ health and schooling will improve. Prior studies have illustrated that the provision 565 
of a menstrual cup can lower rates of reproductive tract and sexually transmitted infections (26); 566 
and that the provision of cash transfer impacts positively on girls’ schooling outcomes (8, 13).  567 
Moreover, evidence is building that enrolment and consistent attendance in school acts as a social 568 
vaccine with multiple benefits for girls(6, 15). This trial will determine if provision of a menstrual 569 
solution alone, or in combination with cash transfer directly to schoolgirls can improve their life 570 
chances, in terms of reducing their risk of HIV, STI (HSV-2), and school dropout. In our trial, we 571 
postulate the interventions tested (cups alone, CT alone, or cups and CT) will lead to a reduction in 572 
schoolgirls’ exposure to sexual and reproductive harms, while increasing their opportunity to 573 
complete their schooling, compared with controls. Enrolment, intervention and follow-up of 574 
participants across a wide geographical area in rural Africa requires a strong collaboration with 575 
schools, communities and organisations. The collaboration in western Kenya between KEMRI, LSTM, 576 
SWAP, CDC and government of Kenya (GoK) provides this. Parallel small group sessions evaluating 577 
programme fidelity and uptake will inform and strengthen the development of programmatic 578 
materials for implementation, should the trial show positive outcomes.  579 
Our research will be communicated to the UK and Kenyan public, Kenyan local, county and national 580 
ministries, NGO and aid agencies, national and international universities, research groups, 581 
international development and aid agencies, donor organizations, and international agencies setting 582 
global policy. We will use multiple communication strategies to target information to the correct 583 
audience, as appropriate. Much will be through face-to-face interactions at workshops, meetings, 584 
local forum presentations, and international conferences. Communication through technology 585 
transfer will be used to disseminate more widely to a broader audience, through online networks, 586 
webinars, online news, blogs, and publication portals.  587 
 588 
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We hope that if the interventions prove to be successful and our communication strategy sound, this 589 
trial could contribute to improved retention of adolescent girls in school, and could have multiple 590 
benefits for health and education services, and national and global level development.  This growing 591 
evidence base must be used to help girls complete their educations and become financially 592 
independent adults, better manage their own menstrual hygiene, and reduce the negative psycho-593 
social pressures and stigma leading to sexual exploitation, violence, illness, premature marriage, and 594 
death during childbirth. Cascading benefits may include that communities will benefit from an 595 
increase in social capital, and a reduction in resources required to support unemployed, sick, and 596 
pregnant girls. Evidence-based-policy will lead to schools being beneficiaries, by improving girls’ 597 
experience of menstrual care in school; and teachers will benefit from girls’ improved attention in 598 
class and equitable teaching. As more girls complete education, there will be greater opportunity for 599 
training female teachers, redressing the gender imbalance. More engaged pupils will increase 600 
teachers’ job satisfaction and better grades will raise school profiles. Partnerships between 601 
education and the health sector will be strengthened. Economic benefits would translate nationally; 602 
for example, researchers estimate that in Kenya, if all 1.6m adolescent girls were able to complete 603 
secondary school, and the ~220,000 girls who were pregnant and delivered could be educated, there 604 
would be a cumulative effect adding up to £2.1 billion towards Kenya’s gross income per year (4). 605 
Implementation of successful interventions globally will increase the number of girls completing 606 
school, reducing the current global estimate of 44m adolescent girls out of school. Implementing 607 
interventions that retain girls through secondary school will have global economic benefits, as it is 608 
estimated that countries growth rates would increase on average by ~1% annually if girls’ education 609 
was raised one level higher (i.e. secondary status). Interventions will reduce the prevalence of teen 610 
births and poor maternal outcomes, and the rate of new HIV infections in adolescence which 611 
currently account for ~40% of new infections. This will decrease the burden of HIV programme costs 612 
for antiretroviral drugs and antenatal care to prevent mother to child transmission. 613 
 614 
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List of abbreviations 615 
95% CI 95 percent Confidence Interval 
AE Adverse event  
AIDS  Acquired Immunodeficiency Syndrome 
ART Antiretroviral therapy 
CDC Centers for Disease Control and Prevention 
CHW Community Health Worker 
CRF Case Record Form 
CRO Contract Research Organization 
CT Cash transfer 
DfID 
 
 
Department for International Development, UK 
 
DHSC UK Department of Health and Social Care 
DMEC Data Monitoring and Ethics Committee 
DSMB Data Safety Monitoring Board 
ELISA Enzyme linked immunosorbent assay 
ERC Ethics Research Committee 
FDA Food and Drug Administration 
FGD Focus group discussions 
GCP Good Clinical Practice 
GEE Generalised Estimating Equation 
GMP Good Manufacturer Practice 
HDSS Health and Demographic Surveillance System 
HIV  Human immunodeficiency virus 
HTC HIV testing and counselling 
HSV-2 Human simplex virus type 2 
IDI In-depth interviews 
IRB  Institutional Review Board 
ITT Intention to Treat 
JGHT Joint Global Health Trials 
KEMRI Kenya Medical Research Institute 
LSTM  Liverpool School of Tropical Medicine 
MHM Menstrual hygiene management 
MoEST Ministry of Education, Science and Technology 
MoH Ministry of Health 
MRC Medical Research Council, UK 
PCR Polymerase Chain Reaction 
PE Protective efficacy 
PP 
QoL 
Per protocol 
Quality of life 
RCT Randomised Controlled Trial 
REC Research Ethics Committee 
RR Relative risk 
RTI Reproductive tract infections 
SAE Serious adverse event 
 
 
SAP Statistical Analysis Plan 
SOP Standard Operating Procedure 
SRH Sexual and reproductive health 
STI Sexually transmitted infections 
SWAP Safe Water and AIDS Project 
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tCTU Tropical Clinical Trials Unit 
TSC Trial Steering Committee 
WASH Water, sanitation and hygiene 
WHO  World Health Organization 
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• Socio-behavioral self-reported survey (e.g. SES, sexual and reproductive risk behaviours, 
wellbeing, spending patterns, menstrual management) 
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Cup intervention Cash intervention 
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• Socio-behavioral self-reported survey (e.g. SES, sexual and reproductive risk behaviours, 
wellbeing, spending patterns, menstrual management) 
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• Anthropometric physical assessment 
• Focus Group Discussions 
 
Figure 2: Flowchart of randomisation and study design. The expected number of participants 
randomized to each arm and the percentage of enrolled expected to contribute to outcomes 
indicated (estimated FU 80% n=792).  
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